Artwork

内容由Adam Strauss提供。所有播客内容(包括剧集、图形和播客描述)均由 Adam Strauss 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Hamilton Morris - The Secret Agenda To Derail Psychedelic Therapy

1:51:08
 
分享
 

Manage episode 456700254 series 3621753
内容由Adam Strauss提供。所有播客内容(包括剧集、图形和播客描述)均由 Adam Strauss 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this eye-opening premiere of Obsessed with Adam Strauss, Adam sits down with Hamilton Morris—scientist, journalist, and creator of Hamilton’s Pharmacopeia—to uncover the shocking truth behind the FDA’s rejection of a groundbreaking psychedelic therapy. While many believe the decision stemmed from a lack of safety research, Hamilton reveals a far more sinister story: a covert effort by a small group to block this therapy’s approval through underhanded tactics and blatant dishonesty.

Together, Adam and Hamilton unravel the conspiracy that’s putting lives and transformative science at risk. From the work of MAPS (Multidisciplinary Association for Psychedelic Studies) to the political and personal motives driving opposition to psychedelic therapy, this conversation explores how hidden agendas can shape public health policy and block life-changing treatments.

If you think the story of psychedelic therapy is just about science and safety, think again. This episode digs deep into the power struggles, misinformation, and obsession behind one of the most controversial moments in this burgeoning movement.

Topics Covered:

  • The misconceptions surrounding the FDA’s rejection of psychedelic therapy.
  • The covert efforts to block this therapy and their far-reaching implications.
  • The role of capitalism, politics, and misinformation in the approval process.
  • Why psychedelic therapy could revolutionize mental health treatment.

Key Organizations discussed:

MAPS - A nonprofit organization that developed the psychedelic therapy discussed in this episode and has led clinical trials to bring it to FDA approval. They previously sponsored Adam’s show The Mushroom Cure.

Lykos Therapeutics - The for-profit pharmaceutical arm of MAPS.

Compass Pathways - A for-profit company exploring psilocybin therapy, raising questions about the role of corporate interests in psychedelics. Hamilton used to consult for them.

Psymposia - A media outlet that critically examines the psychedelic industry, including the ethical and political issues surrounding its development.

Join the Obsession:

If you enjoyed this episode, don’t forget to subscribe to Obsessed with Adam Strauss. Share this episode with friends, leave a review, and follow Adam on social media.

And check out Adam's show The Mushroom Cure here.

  continue reading

2集单集

Artwork
icon分享
 
Manage episode 456700254 series 3621753
内容由Adam Strauss提供。所有播客内容(包括剧集、图形和播客描述)均由 Adam Strauss 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this eye-opening premiere of Obsessed with Adam Strauss, Adam sits down with Hamilton Morris—scientist, journalist, and creator of Hamilton’s Pharmacopeia—to uncover the shocking truth behind the FDA’s rejection of a groundbreaking psychedelic therapy. While many believe the decision stemmed from a lack of safety research, Hamilton reveals a far more sinister story: a covert effort by a small group to block this therapy’s approval through underhanded tactics and blatant dishonesty.

Together, Adam and Hamilton unravel the conspiracy that’s putting lives and transformative science at risk. From the work of MAPS (Multidisciplinary Association for Psychedelic Studies) to the political and personal motives driving opposition to psychedelic therapy, this conversation explores how hidden agendas can shape public health policy and block life-changing treatments.

If you think the story of psychedelic therapy is just about science and safety, think again. This episode digs deep into the power struggles, misinformation, and obsession behind one of the most controversial moments in this burgeoning movement.

Topics Covered:

  • The misconceptions surrounding the FDA’s rejection of psychedelic therapy.
  • The covert efforts to block this therapy and their far-reaching implications.
  • The role of capitalism, politics, and misinformation in the approval process.
  • Why psychedelic therapy could revolutionize mental health treatment.

Key Organizations discussed:

MAPS - A nonprofit organization that developed the psychedelic therapy discussed in this episode and has led clinical trials to bring it to FDA approval. They previously sponsored Adam’s show The Mushroom Cure.

Lykos Therapeutics - The for-profit pharmaceutical arm of MAPS.

Compass Pathways - A for-profit company exploring psilocybin therapy, raising questions about the role of corporate interests in psychedelics. Hamilton used to consult for them.

Psymposia - A media outlet that critically examines the psychedelic industry, including the ethical and political issues surrounding its development.

Join the Obsession:

If you enjoyed this episode, don’t forget to subscribe to Obsessed with Adam Strauss. Share this episode with friends, leave a review, and follow Adam on social media.

And check out Adam's show The Mushroom Cure here.

  continue reading

2集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南